Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-07-25 09:48 Tx date 2023-03-23 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$137,626
+172,033 vol $0.80 each |
377,033 | |
Filed 2024-06-21 12:20 Tx date 2023-03-23 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$137,626
+172,033 vol $0.80 each |
||
Filed 2024-06-21 12:35 Tx date 2024-06-18 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,750
-49,000 vol $0.75 each |
272,033 | |
Filed 2024-06-21 12:20 Tx date 2023-03-23 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$137,626
+172,033 vol $0.80 each |
377,033 | |
Filed 2024-06-21 12:09 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-135,000 vol |
||
Filed 2022-07-26 12:29 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-135,000 vol |
||
Filed 2024-06-19 14:30 Tx date 2024-06-03 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,892
+129,200 vol $0.51 each |
258,400 | |
Filed 2024-06-18 09:41 Tx date 2024-06-18 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,100
-20,000 vol $0.66 each |
14,000 | |
Filed 2024-06-17 16:11 Tx date 2024-06-17 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,835
-15,500 vol $0.57 each |
34,000 | |
Filed 2024-06-17 07:20 Tx date 2024-06-14 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,565
-4,500 vol $0.57 each |
49,500 | |
Filed 2024-06-06 15:19 Tx date 2024-06-03 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,892
+129,200 vol $0.51 each |
258,400 | |
Filed 2024-06-06 15:15 Tx date 2024-06-06 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,920
-16,000 vol $0.495 each |
54,000 | |
Filed 2024-05-24 16:14 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,000
+425,000 vol $0.28 each |
3,655,000 | |
Filed 2024-05-24 16:12 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-119,000
-425,000 vol $0.28 each |
0 | |
Filed 2024-05-24 16:11 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,000
+425,000 vol $0.28 each |
425,000 | |
Filed 2024-05-24 16:10 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-119,000
-425,000 vol $0.28 each |
0 | |
Filed 2024-05-24 16:04 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,062,500,000
+425,000 vol $42,500 each |
425,000 | |
Filed 2024-05-24 16:03 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-119,000
-425,000 vol $0.28 each |
0 | |
Filed 2023-11-01 14:44 Tx date 2023-10-30 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Riesenfeld, Gadi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-11-01 14:38 Tx date 2023-07-06 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Riesenfeld, Gadi
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-06-23 15:23 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
||
Filed 2023-06-13 16:33 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
||
Filed 2023-06-13 16:33 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
258,400 | |
Filed 2023-05-11 14:30 Tx date 2023-05-09 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
129,200 | |
Filed 2023-05-09 18:10 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
Filed 2023-05-09 18:09 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
Filed 2023-05-09 18:06 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
497,200 | |
Filed 2023-05-09 18:05 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:04 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 18:04 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 18:02 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 18:01 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:00 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 17:59 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 17:57 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-05-09 17:56 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
||
Filed 2023-05-09 15:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
||
Filed 2023-05-09 15:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-05-09 14:32 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:28 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:23 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
497,200 | |
Filed 2023-05-09 14:18 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:18 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:16 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-26 12:29 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-135,000 vol |
70,000 | |
Filed 2022-07-26 12:26 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
-1,845,000 vol |
205,000 |